Murae Organisor Ltd
₹ 2.09
-4.13%
24 Dec
9:02 a.m.
About
Incorporated in 2012, Earum Pharmaceuticals Ltd manufactures and trades in pharma products[1]
Key Points
- Market Cap ₹ 194 Cr.
- Current Price ₹ 2.09
- High / Low ₹ 3.03 / 1.03
- Stock P/E 263
- Book Value ₹ 2.85
- Dividend Yield 0.00 %
- ROCE 0.79 %
- ROE 0.13 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 0.76 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -45.0% over past five years.
- Company has a low return on equity of 6.02% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 1,543 days.
- Working capital days have increased from 2,490 days to 6,342 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 9m | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 8.83 | 18.57 | 23.34 | 35.42 | 50.70 | 55.11 | 41.08 | 21.04 | 14.09 | 2.54 | 59.04 | |
0.00 | 0.00 | 8.62 | 18.06 | 22.91 | 33.85 | 47.40 | 53.87 | 48.84 | 25.46 | 13.16 | 3.67 | 58.03 | |
Operating Profit | 0.00 | 0.00 | 0.21 | 0.51 | 0.43 | 1.57 | 3.30 | 1.24 | -7.76 | -4.42 | 0.93 | -1.13 | 1.01 |
OPM % | 2.38% | 2.75% | 1.84% | 4.43% | 6.51% | 2.25% | -18.89% | -21.01% | 6.60% | -44.49% | 1.71% | ||
0.00 | 0.00 | 0.01 | 0.06 | 0.35 | 0.41 | 0.05 | 2.27 | 8.93 | 7.70 | 2.26 | 1.52 | 0.00 | |
Interest | 0.00 | 0.00 | 0.06 | 0.39 | 0.52 | 0.72 | 1.04 | 0.97 | 0.93 | 0.08 | 0.29 | 0.26 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.04 | 0.10 | 0.12 | 0.12 | 0.10 | 0.06 | 0.04 |
Profit before tax | 0.00 | 0.00 | 0.16 | 0.16 | 0.24 | 1.24 | 2.27 | 2.44 | 0.12 | 3.08 | 2.80 | 0.07 | 0.97 |
Tax % | 31.25% | 43.75% | 33.33% | 26.61% | 27.31% | 25.82% | 25.00% | 27.92% | 28.93% | 28.57% | |||
0.00 | 0.00 | 0.11 | 0.10 | 0.16 | 0.91 | 1.66 | 1.82 | 0.09 | 2.22 | 1.98 | 0.05 | 0.74 | |
EPS in Rs | 0.20 | 0.32 | 0.46 | 0.83 | 0.04 | 0.00 | 0.05 | 0.05 | 0.00 | 0.00 | |||
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | -45% |
3 Years: | -60% |
TTM: | 1120% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -50% |
3 Years: | -18% |
TTM: | 54% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -10% |
3 Years: | -38% |
1 Year: | 104% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 6% |
3 Years: | 6% |
Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6.17 | 6.17 | 12.34 | 12.34 | 49.42 | 139.42 |
Reserves | 0.00 | 0.00 | 0.86 | 1.26 | 1.42 | 4.61 | 5.64 | 8.25 | 8.33 | 4.39 | 6.37 | 6.42 | 125.57 |
0.00 | 0.00 | 1.14 | 1.90 | 2.06 | 7.21 | 9.58 | 9.28 | 11.33 | 8.74 | 8.74 | 0.00 | 259.69 | |
0.00 | 0.00 | 2.54 | 5.51 | 7.49 | 7.38 | 7.73 | 12.45 | 2.04 | 3.33 | 1.14 | 64.03 | 23.73 | |
Total Liabilities | 0.01 | 0.01 | 4.55 | 8.78 | 11.08 | 19.51 | 23.26 | 36.15 | 27.87 | 28.80 | 28.59 | 119.87 | 548.41 |
0.00 | 0.00 | 0.04 | 0.17 | 0.16 | 0.20 | 0.48 | 0.80 | 0.76 | 0.58 | 0.48 | 0.00 | 0.01 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.01 | 0.01 | 4.51 | 8.61 | 10.92 | 19.31 | 22.78 | 32.32 | 27.11 | 28.22 | 28.11 | 119.87 | 548.40 | |
Total Assets | 0.01 | 0.01 | 4.55 | 8.78 | 11.08 | 19.51 | 23.26 | 36.15 | 27.87 | 28.80 | 28.59 | 119.87 | 548.41 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | -1.80 | -0.26 | 0.09 | -7.09 | -0.48 | -3.45 | -7.10 | 2.61 | 0.26 | -15.92 | |
0.00 | 0.00 | -0.04 | -0.15 | -0.02 | -0.05 | -0.32 | -3.45 | 2.94 | 0.06 | 0.00 | -0.48 | |
0.00 | 0.00 | 1.84 | 0.77 | -0.25 | 6.98 | 0.94 | 6.76 | 2.90 | -2.67 | -0.29 | 28.08 | |
Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.35 | -0.18 | -0.16 | 0.14 | -0.14 | -1.26 | -0.01 | -0.03 | 11.69 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 124.84 | 87.47 | 55.99 | 111.19 | 78.11 | 112.26 | 94.80 | 260.91 | 217.34 | 1,543.35 | ||
Inventory Days | 70.52 | 77.88 | 108.46 | 91.19 | 86.30 | 97.05 | 121.96 | 178.56 | 391.86 | 1,438.74 | ||
Days Payable | 112.93 | 107.21 | 82.75 | 77.11 | 53.85 | 83.42 | 10.18 | 17.64 | -25.37 | 7.09 | ||
Cash Conversion Cycle | 82.43 | 58.13 | 81.69 | 125.27 | 110.56 | 125.89 | 206.58 | 421.84 | 634.57 | 2,975.00 | ||
Working Capital Days | 81.43 | 54.05 | 57.71 | 115.72 | 98.27 | 125.91 | 222.31 | 430.92 | 698.14 | 6,341.52 | ||
ROCE % | 0.00% | 21.78% | 20.83% | 22.16% | 24.94% | 23.93% | 17.38% | 4.24% | 12.32% | 11.68% | 0.79% |
Documents
Announcements
- Addendum To Notice Of The Extra-Ordinary General Meeting ('EGM') Of Murae Organisor Limited (Formerly Known As Earum Pharmaceuticals Limited) To Be Held On Friday, 10Th January, 2025 At 03:00 P.M. Through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM') 12h
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Newspaper Advertisement for Notice of Extra-Ordinary General Meeting is attached herewith.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
20 Dec - Appointment of Mr. Krunalbhai Desai and rights issue schedule.
-
Board Meeting Outcome for Intimation And Outcome Of Board Meeting Held Today I.E., 20Th December, 2024 Under The Regulation 30 Of SEBI (LODR) Regulations, 2015
20 Dec - Appointment of Mr. Krunalbhai Desai and rights issue schedule.
-
Notice Of Extra-Ordinary General Meeting ('EGM') Of The Company
19 Dec - Notice of EGM to appoint auditors and increase share capital.
Business Overview:[1]
Company is in the pharmaceutical business handling marketing, trading and distribution of a wide range of pharmaceutical formulation products, of which 120 products are marketed by company under its own brand, and their manufacturing is outsourced to third parties. Apart from this, company also trades in active pharmaceutical ingredients